Three separate data signals are moving in the same direction on PFE. Short sellers have retreated further. The options market has grown more call-heavy. Borrow costs have halved. Together, they describe a lending and positioning environment that looks nothing like a stock under pressure.
Short interest fell again this week — down to 2.55% of free float as of August 19. That is the lowest level in recent months and extends a retreat that was already underway when the previous notes flagged director buying in early August.
The pace of the exit matters. Shorts fell 12.5% in the week to August 19, following a similar drop the prior week. The absolute level was already low. The speed of the decline suggests active covering, not drift.
The put-call ratio hit 0.8209 on August 19. That is 1.9 standard deviations below the 20-day mean of 0.84. It followed a reading of 0.8155 on August 18 — the lowest point this week.
Both readings came in well below the 20-day average. Calls are dominating relative to recent norms. The PCR's 52-week range runs from 0.64 to 0.94, so the current reading sits in the lower third — leaning bullish but not extreme on a full-year basis.
Cost to borrow fell 51.9% over the past week to 0.28%. A month ago it was above 0.50%. Availability remains extremely wide — effectively unconstrained for any practical borrowing purpose.
This level of CTB means short sellers face minimal friction. The drop confirms the retreat in short interest isn't a forced unwind — it's voluntary.
The Street has been trimming targets. Guggenheim lowered its price target to $31 on August 7, maintaining Buy. JP Morgan held Neutral with a $28 target. B of A stayed Neutral at $26. The consensus price target sits at $28.61 — roughly in line with the current price of $28.24.
Analyst coverage leans mixed. Bulls cite the $60 billion revenue base and international diversification. Bears flag gross-to-net adjustments on Vyndaqel and Ibrance squeezing near-term recognition.
See the live data behind this article on ORTEX.
Open PFE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
